Citizens Financial Group »

Enlivex Therapeutics shares owned by Citizens Financial Group

Quarter-by-quarter ownership of Enlivex Therapeutics (ENLV) shares owned by Citizens Financial Group from 13F filings

Historical chart of Citizens Financial Group investment in Enlivex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enlivex Therapeutics held by Citizens Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enlivex Therapeutics by Citizens Financial Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $241k 231k 1.04

More positions owned by Citizens Financial Group

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Vanguard Index Fds Value Etf (VTV)
JPMorgan Chase & Co. (JPM)
Procter & Gamble Company (PG)
Facebook Cl A (META)
Ishares Core Msci Emkt (IEMG)

View all positions for Citizens Financial Group

Top funds holding Enlivex Therapeutics

Citizens Financial Group
Morgan Stanley
Renaissance Technologies
Citadel Advisors
Susquehanna International
XTX Topco
Two Sigma Securities
Sigma Investment Counselors
Jane Street
Hrt Financial
Prosperity Consulting Group
Neuberger Berman Group
Two Sigma Investments
SkyView Investment Advisors
Wells Fargo & Company

View all funds holding Enlivex Therapeutics